A study co-led by researchers at the University of Hawaiʻi at Mānoa has found that exposure to per- and polyfluoroalkyl substances (PFAS)—commonly ...

Choline is an essential nutrient that plays a key role in fetal growth and development, supports cell structure and function, ...

A new study co-led by the Southern California Superfund Research and Training Program for PFAS Assessment, Remediation and ...

Phase 1 results confirm investigational drug-candidate G1090N has a favorable safety and tolerability profile, supporting further clinical ...

Decades of research show that early psychosocial stress, including chronic exposure to adversity, can shape how a child's ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim Labs”), a pharmaceutical and biotechnology services company that is focused on providing testing of drugs and drug candidates in ...

The FDA rejected Sanofi's MS drug tolebrutinib, citing liver injury risks, unclear benefits, and trial data that failed to ...

SHENZHEN, China, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a ...

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

Rezdiffra FDA approval fuels sales; expansion to F4 MASH cirrhosis with 2027 trial data. Read more about MDGL stock here.

Gyre Pharmaceuticals completed a Pre-NDA meeting with China’s CDE, which agreed that the existing Phase 3 clinical data support a conditional approval filing for Hydronidone and priority review ...

Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and ...